期刊文献+

抗结核药药疹与斑贴试验

Drug Rash by Anti-tuberculosis Drugs and Patch Test
下载PDF
导出
摘要 结核病是一种常见的慢性呼吸道传染性疾病,其治疗周期长,用药比较复杂,抗结核药物不良反应较多,引起的药疹也比较常见,如何确定致敏药物对临床诊治有重要意义。寻找药物致敏原在临床中一直很受关注,检测方法没有统一标准,斑贴试验是检测迟发型过敏反应致敏原的主要手段,进行药物斑贴试验的目的是找出可疑致敏药物,为临床诊治提供依据,而且药物斑贴试验在临床应用中相对比较安全,操作简便,结核病患者常为联合用药,斑贴试验可以同时检测多种药物,在临床药疹的诊断中应用越来越广泛,在对抗结核药引起的药疹的诊治中能够提供重要的依据。 Tuberculosis (TB) is a common chronic respiratory infectious disease, the treatment cycle is long, and the anti-tuberculosis drug is more complex. There is more adverse reactions of anti-tuberculosis drugs, and drug eruption is more common caused by anti-tb drugs. How to determine the sensitization drugs for clinical diagnosis and treatment is important. Looking for drugs allergen has been very popular in the clinical, there is no unified standard analytical methods. Patch test is the principal means of delayed allergy. The purpose of drug patch test is to identify suspicious sensitization drugs, provide the basis for clinical diagnosis and treatment, and drug patch test is relatively safe and simple in clinical application, The drugs of TB patients are often combination, patch test can detect a variety of drugs, it is more and more widely applied in the clinical diagnosis of drug eruption, it can provide important basis in the diagnosis and treatment of drug eruption.
作者 周书会 侯志丽 ZHOU Shuhui;HOU Zhili(Dermatological Department,Tianjin Haihe Hospital,Tianjin 300350,China;Tuberculosis Department,Tianjin Haihe Hospital,Tianjin 300350,China)
出处 《继续医学教育》 2018年第9期86-87,共2页 Continuing Medical Education
关键词 抗结核药 药疹 斑贴试验 anti-tuberculosis drug rash patch test
  • 相关文献

参考文献14

二级参考文献143

  • 1杨志芳.抗结核药物引起药疹46例临床分析[J].中国麻风皮肤病杂志,2004,20(6):593-594. 被引量:5
  • 2李焱,汤雪薇,吴洁莹,袁思敏,杨昕,黄以宁,廖灿.广东汉族人群HLA-B基因多态性研究[J].中华医学遗传学杂志,2006,23(1):50-54. 被引量:16
  • 3牛红喜,耿龙,尚英彬,徐媛媛,宋芳吉,陈洪铎.191例重症药疹临床分析[J].中华皮肤科杂志,2006,39(9):530-532. 被引量:26
  • 4陈子怡,周列民,周珏倩,李伟峰,程芙蓉,潘军利.抗癫痫药物所致重型药疹及危险因素分析[J].医学信息(西安上半月),2006,19(11):1989-1990. 被引量:15
  • 5范洪斌.卡马西平药疹26例临床分析[J].皮肤病与性病,1996,18(4):14-14. 被引量:9
  • 6杨国亮 王侠生.现代皮肤病学[M].上海:上海医科大学出版社,1995.393-395.
  • 7许怀麟 凌绍贤 等.大疱性表皮松解型药疹临床分析(附34例报告)[J].临床皮肤科杂志,1993,22(3):159-159.
  • 8FDA. Table of Valid Genomic Biomarkers in the Context of Approved Drug Labels[OL]. http://www.fda.gov/Drugs/ ScienceResearch/ResearchAreas/Pharmacogenetics/ucm083378. htm. 2010-08-06/2010-10-15.
  • 9Allegra C J, Jessup JM, Somerfield MR, et al. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy[J]. J Clin Oncol. 2009; 27(12):2091-6.
  • 10Amado RG, Wolf M, Peeters M, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer[J]. J Clin Oncol. 2008; 26(10): 1626-34.

共引文献127

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部